A detailed history of Dohj, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Dohj, LLC holds 9,490 shares of BIIB stock, worth $1.5 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
9,490
Previous 7,932 19.64%
Holding current value
$1.5 Million
Previous $1.84 Million 0.05%
% of portfolio
0.42%
Previous 0.46%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$189.07 - $236.8 $294,571 - $368,934
1,558 Added 19.64%
9,490 $1.84 Million
Q2 2024

Aug 09, 2024

BUY
$190.52 - $236.72 $262,155 - $325,726
1,376 Added 20.99%
7,932 $1.84 Million
Q1 2024

Apr 15, 2024

BUY
$212.02 - $267.71 $610,829 - $771,272
2,881 Added 78.39%
6,556 $1.41 Million
Q4 2023

Feb 02, 2024

BUY
$222.59 - $267.94 $818,018 - $984,679
3,675 New
3,675 $950,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Dohj, LLC Portfolio

Follow Dohj, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dohj, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dohj, LLC with notifications on news.